{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:43:10Z","timestamp":1792698190826,"version":"4.5.0"},"reference-count":51,"publisher":"BMJ","issue":"10","license":[{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"unspecified","delay-in-days":21,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"USC Dornsife SOAR","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"DOI":"10.13039\/100000892","name":"Prostate Cancer Foundation","doi-asserted-by":"publisher","award":["22TACT03"],"award-info":[{"award-number":["22TACT03"]}],"id":[{"id":"10.13039\/100000892","id-type":"DOI","asserted-by":"publisher"}]},{"name":"USC Michelson Convergent Science Institute in Cancer","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"USC Provost Research Fellowship","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"Alan Joseph Endowed Fellowship","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"USC Norris Comprehensive Cancer Center","award":["P30CA014089"],"award-info":[{"award-number":["P30CA014089"]}]},{"name":"Vassiliadis Research Fund","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2026,9,10]]},"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1136\/jitc-2026-015764","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:05:10Z","timestamp":1792695910000},"page":"e015764","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Clonal circulating tumor cell mobilization following chimeric antigen receptor T-cell therapy in metastatic castration-resistant prostate cancer"],"prefix":"10.1136","volume":"14","clinical-trial-number":[{"clinical-trial-number":"nct03873805","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03873805","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03873805","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Doanna M","family":"Pham","sequence":"first","affiliation":[{"name":"Convergent Science Institute in Cancer, University of Southern California, Los Angeles, California, USA"},{"name":"Department of Biological Sciences, University of Southern California, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Rivera","sequence":"additional","affiliation":[{"name":"Convergent Science Institute in Cancer, University of Southern California, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avery","family":"Lin","sequence":"additional","affiliation":[{"name":"Convergent Science Institute in Cancer, University of Southern California, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Udov","sequence":"additional","affiliation":[{"name":"Convergent Science Institute in Cancer, University of Southern California, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren N","family":"Adkins","sequence":"additional","affiliation":[{"name":"Department of Medicine, Keck School of Medicine of USC, Los Angeles, California, USA"},{"name":"KSOM\/Norris Center for Cancer Cellular Immunotherapy Research, USC Norris Comprehensive Cancer Center, Keck School of Medicine of USC, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catalina","family":"Martinez","sequence":"additional","affiliation":[{"name":"Department of Medicine, Keck School of Medicine of USC, Los Angeles, California, USA"},{"name":"KSOM\/Norris Center for Cancer Cellular Immunotherapy Research, USC Norris Comprehensive Cancer Center, Keck School of Medicine of USC, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J","family":"Forman","sequence":"additional","affiliation":[{"name":"Hematologic Malignancies Research Institute, City of Hope, Duarte, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8136-2112","authenticated-orcid":false,"given":"Saul J","family":"Priceman","sequence":"additional","affiliation":[{"name":"Department of Medicine, Keck School of Medicine of USC, Los Angeles, California, USA"},{"name":"KSOM\/Norris Center for Cancer Cellular Immunotherapy Research, USC Norris Comprehensive Cancer Center, Keck School of Medicine of USC, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5990-298X","authenticated-orcid":false,"given":"Tanya B","family":"Dorff","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, City of Hope, Duarte, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2629-4505","authenticated-orcid":false,"given":"Peter","family":"Kuhn","sequence":"additional","affiliation":[{"name":"Convergent Science Institute in Cancer, University of Southern California, Los Angeles, California, USA"},{"name":"Department of Biological Sciences, University of Southern California, Los Angeles, California, USA"},{"name":"Department of Medicine, Keck School of Medicine of USC, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie N","family":"Shishido","sequence":"additional","affiliation":[{"name":"Convergent Science Institute in Cancer, University of Southern California, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,10,22]]},"reference":[{"key":"2026102212050798000_14.10.e015764.1","first-page":"451","article-title":"Global Cancer Statistics 2022: the trends projection analysis","volume":"10","author":"Chhikara","year":"2023","journal-title":"Chemical Biology Letters"},{"key":"2026102212050798000_14.10.e015764.2","doi-asserted-by":"publisher","DOI":"10.1159\/000477852"},{"key":"2026102212050798000_14.10.e015764.3","doi-asserted-by":"crossref","first-page":"176","DOI":"10.17159\/2078-5151\/2021\/v59n4a3327","article-title":"Costs of managing castrate-resistant metastatic prostate cancer patients at Inkosi Albert Luthuli Central Hospital","volume":"59","author":"Gabela","year":"2021","journal-title":"S Afr J Surg"},{"key":"2026102212050798000_14.10.e015764.4","unstructured":"Prostate Cancer \u2014 SEER Cancer Stat Facts. 2022 Available: https:\/\/seer.cancer.gov\/statfacts\/html\/prost.html"},{"key":"2026102212050798000_14.10.e015764.5","unstructured":"Survival Rates for Prostate Cancer \u2014 American Cancer Society. 2022 Available: https:\/\/www.cancer.org\/cancer\/types\/prostate-cancer\/detection-diagnosis-staging\/survival-rates.html"},{"key":"2026102212050798000_14.10.e015764.6","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000019760","article-title":"Metastatic castration-resistant prostate cancer: Academic insights and perspectives through bibliometric analysis","volume":"99","author":"He","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"2026102212050798000_14.10.e015764.7","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2490-14-55","article-title":"Changing paradigms in management of metastatic Castration Resistant Prostate Cancer (mCRPC)","volume":"14","author":"Gupta","year":"2014","journal-title":"BMC Urol"},{"key":"2026102212050798000_14.10.e015764.8","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5858\/arpa.2019-0124-RA","article-title":"Clinicopathologic Diagnostic Approach to Aggressive Variant Prostate Cancer","volume":"144","author":"Manucha","year":"2020","journal-title":"Arch Pathol Lab Med"},{"key":"2026102212050798000_14.10.e015764.9","doi-asserted-by":"crossref","unstructured":"Pourmir I , Elaidi R , Maaradji Z , et al . Longitudinal study of advanced non-small cell lung cancer with initial durable clinical benefit to immunotherapy: strategies for anti-PD-1\/PD-L1 continuation beyond progression. Cancers (Basel) 2023;15. doi:10.3390\/cancers15235587","DOI":"10.3390\/cancers15235587"},{"key":"2026102212050798000_14.10.e015764.10","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12865-024-00676-2","article-title":"Long-term survival after local immunotherapy for malignant gliomas: a retrospective study with 20 years follow-up","volume":"25","author":"Duan","year":"2024","journal-title":"BMC Immunol"},{"key":"2026102212050798000_14.10.e015764.11","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-04390-6"},{"key":"2026102212050798000_14.10.e015764.12","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/jamaoncol.2018.5801","article-title":"Analysis of the Prevalence of Microsatellite Instability in Prostate Cancer and Response to Immune Checkpoint Blockade","volume":"5","author":"Abida","year":"2019","journal-title":"JAMA Oncol"},{"key":"2026102212050798000_14.10.e015764.13","doi-asserted-by":"publisher","DOI":"10.1038\/nature25501"},{"key":"2026102212050798000_14.10.e015764.14","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.eururo.2020.12.040","article-title":"The Mutational Landscape of Metastatic Castration-sensitive Prostate Cancer: The Spectrum Theory Revisited","volume":"80","author":"Deek","year":"2021","journal-title":"Eur Urol"},{"key":"2026102212050798000_14.10.e015764.15","doi-asserted-by":"crossref","unstructured":"Kwon ED , Drake CG , Scher HI , et al . Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial. Lancet Oncology 2014;15. doi:10.1016\/S1470-2045(14)70189-5","DOI":"10.1016\/S1470-2045(14)70189-5"},{"key":"2026102212050798000_14.10.e015764.16","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-02979-8"},{"key":"2026102212050798000_14.10.e015764.17","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01726-1"},{"key":"2026102212050798000_14.10.e015764.18","doi-asserted-by":"publisher","DOI":"10.1002\/pros.23214"},{"key":"2026102212050798000_14.10.e015764.19","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(02)02291-4"},{"key":"2026102212050798000_14.10.e015764.20","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.3390\/curroncol29050242","article-title":"Enrichment-Free Single-Cell Detection and Morphogenomic Profiling of Myeloma Patient Samples to Delineate Circulating Rare Plasma Cell Clones","volume":"29","author":"Ndacayisaba","year":"2022","journal-title":"Curr Oncol"},{"key":"2026102212050798000_14.10.e015764.21","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41698-023-00446-0","article-title":"Targeted single-cell proteomic analysis identifies new liquid biopsy biomarkers associated with multiple myeloma","volume":"7","author":"Setayesh","year":"2023","journal-title":"NPJ Precis Oncol"},{"key":"2026102212050798000_14.10.e015764.22","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1002\/pros.23896","article-title":"Detection and isolation of disseminated tumor cells in bone marrow of patients with clinically localized prostate cancer","volume":"79","author":"Cackowski","year":"2019","journal-title":"Prostate"},{"key":"2026102212050798000_14.10.e015764.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2006.09.018"},{"key":"2026102212050798000_14.10.e015764.24","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-1355"},{"key":"2026102212050798000_14.10.e015764.25","doi-asserted-by":"crossref","unstructured":"Brady L , Hayes B , Sheill G , et al . Platelet cloaking of circulating tumour cells in patients with metastatic prostate cancer: results from ExPeCT, a randomised controlled trial. PLoS One 2020;15. doi:10.1371\/journal.pone.0243928","DOI":"10.1371\/journal.pone.0243928"},{"key":"2026102212050798000_14.10.e015764.26","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1411082111"},{"key":"2026102212050798000_14.10.e015764.27","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.55.3487"},{"key":"2026102212050798000_14.10.e015764.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.11.046"},{"key":"2026102212050798000_14.10.e015764.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2015.11.025"},{"key":"2026102212050798000_14.10.e015764.30","doi-asserted-by":"publisher","DOI":"10.1088\/1478-3975\/9\/1\/016003"},{"key":"2026102212050798000_14.10.e015764.31","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-017-1105-2"},{"key":"2026102212050798000_14.10.e015764.32","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-21-0383"},{"key":"2026102212050798000_14.10.e015764.33","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17172779","article-title":"Automated Single-Cell Analysis in the Liquid Biopsy of Breast Cancer","volume":"17","author":"Shishido","year":"2025","journal-title":"Cancers (Basel)"},{"key":"2026102212050798000_14.10.e015764.34","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2012.039"},{"key":"2026102212050798000_14.10.e015764.35","unstructured":"Li H . Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. arXiv 2013. doi:10.48550\/arXiv.1303.3997"},{"key":"2026102212050798000_14.10.e015764.36","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-018-1603-1","article-title":"Cell Hashing with barcoded antibodies enables multiplexing and doublet detection for single cell genomics","volume":"19","author":"Stoeckius","year":"2018","journal-title":"Genome Biol"},{"key":"2026102212050798000_14.10.e015764.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2016.03.081"},{"key":"2026102212050798000_14.10.e015764.38","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41523-022-00390-5","article-title":"Disease characterization in liquid biopsy from HER2-mutated, non-amplified metastatic breast cancer patients treated with neratinib","volume":"8","author":"Shishido","year":"2022","journal-title":"NPJ Breast Cancer"},{"key":"2026102212050798000_14.10.e015764.39","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-4100"},{"key":"2026102212050798000_14.10.e015764.40","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s43856-025-01024-0","article-title":"Simultaneous expression of epithelial and immune cell markers in circulating tumor cells identified in patients with stage 4 breast cancer","volume":"5","author":"Higa","year":"2025","journal-title":"Commun Med (Lond)"},{"key":"2026102212050798000_14.10.e015764.41","doi-asserted-by":"crossref","unstructured":"Naghdloo A , Kamal M , Tessone D , et al . Caught in the Act: Tumor-Immune Interactions in Circulation of Patients with Immune Marker Positive Circulating Tumor Cells. Cancers (Basel) 2025;17. doi:10.3390\/cancers17223667","DOI":"10.3390\/cancers17223667"},{"key":"2026102212050798000_14.10.e015764.42","doi-asserted-by":"crossref","first-page":"1744-51","DOI":"10.1002\/cncr.34704","article-title":"Bone marrow niche chemoprotection of metastatic solid tumors mediated by CYP3A4","volume":"129","author":"Ghiaur","year":"2023","journal-title":"Cancer"},{"key":"2026102212050798000_14.10.e015764.43","doi-asserted-by":"crossref","first-page":"2407662","DOI":"10.1002\/advs.202407662","article-title":"Osteoblast-derived ECM1 promotes anti-androgen resistance in bone metastatic prostate cancer","volume":"12","author":"Wang","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"2026102212050798000_14.10.e015764.44","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-11-887067"},{"key":"2026102212050798000_14.10.e015764.45","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V126.23.184.184","article-title":"Anti-CD19 Chimeric Antigen Receptor-Modified T Cell Therapy for B Cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia: Fludarabine and Cyclophosphamide Lymphodepletion Improves In Vivo Expansion and Persistence of CAR-T Cells and Clinical Outcomes","volume":"126","author":"Turtle","year":"2015","journal-title":"Blood"},{"key":"2026102212050798000_14.10.e015764.46","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1016\/j.ymthe.2020.06.025","article-title":"Reactive myelopoiesis triggered by lymphodepleting chemotherapy limits adoptive T-cell therapy efficacy","volume":"28","author":"Innamarato","year":"2020","journal-title":"Mol Ther"},{"key":"2026102212050798000_14.10.e015764.47","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-020-07376-1","article-title":"Chemotherapy-induced release of circulating-tumor cells into the bloodstream in collective migration units with cancer-associated fibroblasts in metastatic cancer patients","volume":"20","author":"Ortiz-Otero","year":"2020","journal-title":"BMC Cancer"},{"key":"2026102212050798000_14.10.e015764.48","doi-asserted-by":"crossref","unstructured":"Li D , Chen C , Li J , et al . A pilot study of lymphodepletion intensity for peripheral blood mononuclear cell-derived neoantigen-specific CD8\u2009+\u2009T cell therapy in patients with advanced solid tumors. Nat Commun 2023;14. doi:10.1038\/s41467-023-39225-7","DOI":"10.1038\/s41467-023-39225-7"},{"key":"2026102212050798000_14.10.e015764.49","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2021.02.024"},{"key":"2026102212050798000_14.10.e015764.50","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.3370"},{"key":"2026102212050798000_14.10.e015764.51","unstructured":"BloodPAC Consortium . Data from: BPDC000163. BloodPAC Data Commons. 2026 Available: https:\/\/data.bloodpac.org\/discovery\/BPDC000163\/"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2026-015764","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:05:15Z","timestamp":1792695915000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2026-015764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":51,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10,22]]},"published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10.1136\/jitc-2026-015764"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2026-015764","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10]]}}}